News coverage about Amedica Corporation (NASDAQ:AMDA) has trended somewhat positive on Thursday, according to Accern. The research firm identifies negative and positive news coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Amedica Corporation earned a media sentiment score of 0.25 on Accern’s scale. Accern also gave media coverage about the medical equipment provider an impact score of 46.7571954544984 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

Amedica Corporation (NASDAQ AMDA) traded down 2.265% during mid-day trading on Thursday, hitting $0.315. 57,716 shares of the stock traded hands. Amedica Corporation has a 12 month low of $0.26 and a 12 month high of $1.13. The stock’s market cap is $8.32 million. The stock has a 50-day moving average price of $0.34 and a 200-day moving average price of $0.36.

TRADEMARK VIOLATION NOTICE: “Amedica Corporation (AMDA) Receiving Somewhat Positive Press Coverage, Analysis Finds” was originally posted by Daily Political and is owned by of Daily Political. If you are viewing this article on another publication, it was illegally stolen and republished in violation of United States and international copyright and trademark legislation. The correct version of this article can be read at

Amedica Corporation Company Profile

Amedica Corporation is a commercial biomaterial company. The Company is a vertically integrated silicon nitride orthopedic medical device manufacturer. It is focused on using its silicon nitride ceramic technology platform to develop, manufacture and sell a range of medical devices. It is also engaged in developing wear- and corrosion-resistant implant components for hip and knee arthroplasty.

Insider Buying and Selling by Quarter for Amedica Corporation (NASDAQ:AMDA)

Receive News & Ratings for Amedica Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedica Corporation and related companies with's FREE daily email newsletter.